A Randomized, Open Label, Dose Titration Study to Evaluate the Efficacy and Safety of Pitavastatin Compared to atoRvastatin in Type 2 dIabeTes Mellitus With Hypercholesterolemia.
Phase of Trial: Phase IV
Latest Information Update: 29 Mar 2012
At a glance
- Drugs Atorvastatin; Pitavastatin
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms ESPRIT
- Sponsors JW Pharmaceutical
- 10 Jun 2017 Biomarkers information updated
- 29 Mar 2012 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 29 Mar 2012 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.